header-1-temp

New Test Available:

Visit: www.ivygenelabs.com

See important update below!

Exciting Update: New Test Available!

We are excited to bring you a new advancement in the fight against cancer, the IvyGene test. The IvyGene test is a non-invasive blood test that confirms cancer presence and provides a quantitative score derived from specific cell-free DNA methylation sites shown to be elevated when cancer is present. The IvyGene Test is affordable, highly accurate and sensitive, and takes only 5 business days for results.

The technology behind the test has been published in Nature Materials and the Proceedings of the National Academy of Sciences (PNAS).

The IvyGene test provides quantifiable information on cancer presence and has been demonstrated to be highly useful to confirm the presence of breast, colon, liver and lung cancers.

 

What are the benefits of IvyGene test?

  • Confirmation of Cancer Presence
  • Quantitative Data about Cancer Presence
  • 5 Business Days for Results
  • Pre-paid Shipping
  • Technical Consultations Available

Visit: www.ivygenelabs.com

Step 1: Ask your physician to order a test kit online

Step 2: Your physician performs a blood draw

Step 3: Samples are sent pre-paid and overnighted to the lab

Step 4: Physician receives your results 5 business days later




Note:  The ONCOblot Test is not commercially available.  We are currently referring all interested physicians and patients to review the capabilities of the IvyGene test at this time.

The ONCOblot test is based on the presence ENOX2.  The ENOX2 protein species in the blood is present in malignant cells.  These proteins can be detected in early development.  The ONCOblot® Test identifies the ENOX2 markers.

Dr. James Morré and Dr. David Taggart speak to the history and future of the ONCOblot® test.

In the News

Read the Published Peer-Reviewed Study, January 2016:  “ENOX2 proteins from malignant mesothelioma are detected 4-10 years in advance of clinical symptoms.”

The ONCOblot® Test reveals the tissue of origin of the ENOX2 protein. The ONCOblot® database contains the following 25+ ENOX2 transcript variants:

• Bladder
• Breast
• Cervical
• Colorectal
• Endometrial
• Esophageal
• Gastric
• Hepatocellular
• Kidney

• Leukemia
• Non-Small cell
• Lung Small cell
• Lymphoma
• Melanoma
• Mesothelioma
• Myeloma
• Ovarian

• Pancreatic
• Prostate
• Sarcoma
• Squamous Cell
• Follicular Thyroid
• Papillary Thyroid
• Testicular Germ Cell
• Uterine

Upcoming Events

Click here for information regarding events ONCOblot has attended.
And, the Research Award presented to Drs. Morre’ at the AMMG, May 15, 2016!